EP 2943214 A1 20151118 - USE OF FACTOR XA IN THE PREVENTION OR TREATMENT OF HAEMORRHAGIC EVENTS FOLLOWING THE TAKING OF ANTICOAGULANTS
Title (en)
USE OF FACTOR XA IN THE PREVENTION OR TREATMENT OF HAEMORRHAGIC EVENTS FOLLOWING THE TAKING OF ANTICOAGULANTS
Title (de)
VERWENDUNG VON FAKTOR XA ZUR VORBEUGUNG ODER BEHANDLUNG VON HÄMORRHAGISCHEN EREIGNISSEN NACH DER EINNAHME VON ANTIKOAGULANTIEN
Title (fr)
UTILISATION DU FACTEUR XA DANS LA PREVENTION OU LE TRAITEMENT D'EVENEMENTS HEMORRAGIQUES A LA SUITE DE LA PRISE D'ANTICOAGULANTS
Publication
Application
Priority
- FR 1350278 A 20130111
- FR 2014050020 W 20140108
Abstract (en)
[origin: WO2014108632A1] The present invention concerns factor Xa for the use thereof in the prevention or treatment, in a patient, in particular a human or animal, of haemorrhagic events induced by the taking of anticoagulants.
IPC 8 full level
A61K 38/36 (2006.01); A61P 7/04 (2006.01)
CPC (source: EP US)
A61K 31/5377 (2013.01 - EP US); A61K 38/36 (2013.01 - EP US); A61K 38/4846 (2013.01 - EP US); A61P 7/04 (2017.12 - EP); C12Q 1/56 (2013.01 - US); C12Y 304/21006 (2013.01 - EP US); G01N 2333/96463 (2013.01 - US)
Citation (search report)
See references of WO 2014108632A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2014108632 A1 20140717; EP 2943214 A1 20151118; FR 3000895 A1 20140718; FR 3000895 B1 20170224; US 2015343033 A1 20151203; US 9700603 B2 20170711
DOCDB simple family (application)
FR 2014050020 W 20140108; EP 14703112 A 20140108; FR 1350278 A 20130111; US 201414654595 A 20140108